Life sciences and Health - Japan-en
Japan offers significant opportunities for Dutch companies and researchers in the Life Sciences & Health (LSH) sector. Both nations face shared challenges like aging populations and rising healthcare demands, making them natural partners to drive innovation and improve health outcomes.
Let's connect
Digital Health
Japan's healthcare system is increasingly adopting digital health technologies to address critical challenges like healthcare worker shortages and uneven access to medical care, particularly in rural areas.
With growing acceptance of telemedicine and AI diagnostics, there is a strong push to modernize healthcare services and integrate digital tools into patient care.
Notable examples include platforms like LINE Doctor and MICIN, which are driving the digital health transformation.
Regenerative Medicine
Japan is proactively advancing initiatives to bridge cutting-edge research with clinical trials and industrial applications, establishing itself as a global leader in the field of regenerative medicine. Furthermore, the country has solidified its position as an advanced treatment hub for iPS cell research and cell/gene therapies.
Innovation in this rapidly growing market is being further accelerated by strong government support and strategic partnerships with the private sector.
As part of these efforts, RegMed XB, a Dutch-Flemish public-private partnership for regenerative medicine, signed a Memorandum of Understanding (MoU) with the newly established Nakanoshima Qross medical hub in October 2024. In January 2026, RegMed XB signed a second MoU with the Japan Society for Regenerative Medicine.
Through collaboration between Japan and the Netherlands, we aim to build a global ecosystem that rapidly delivers safe, ethical, and cutting-edge therapies to patients.
Healthy Aging
Japan has one of the world's oldest populations, with people aged 65 and over accounting for more than 30% of the population. This demographic shift is driving demand for new approaches to elderly care, preventive medicine, and improving quality of life.
The government has designated healthy aging as a key policy priority, encouraging innovation in medical devices, healthcare services, and infrastructure that support older adults.
One example is Japan's adoption of robotic caregivers and remote health monitoring systems to support independent living and improve elderly care.
Japanese Innovation and Dutch Expertise: A Perfect Match
Dutch companies and researchers offer world-class expertise within Japan's evolving healthcare landscape.
‣ Advanced digital health solutions such as telemedicine and AI diagnostic technologies
‣ Innovations in regenerative medicine and biotechnology
‣ Development of age-friendly environmental design and assistive devices
To succeed in the Japanese market
We explain Japan's unique business culture and regulatory environment to Dutch companies seeking to enter the Japanese market, helping them build long-term partnerships with Japanese companies and research institutions.
How We Can Support You
The Embassy of the Kingdom of the Netherlands in Japan and the Consulate-General of the Kingdom of the Netherlands in Osaka provide support to Dutch companies and researchers to understand and adapt to the Japanese market.
- Providing insights into key market trends and business opportunities
- Facilitating networking with Japanese companies, researchers, and policymakers
- Guidance on regulations and cultural practices
Driving Japan-Netherlands Relations
Japan and the Netherlands are partners who can grow stronger together. Japanese companies and researchers, please inquire about how collaboration and co-creation with Dutch companies and researchers exploring opportunities in the LSH field can benefit you.